Strength
200 mg/mL
Manufacturer
UCB, Inc.NDC
50474071081
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
1/1/2026
Active Ingredients
CERTOLIZUMAB PEGOLApproval Type
Biologic (BLA)
FDA Application
BLA125160On Market Since
5/14/2009
Pharmacological Classes
Price Statistics
The NADAC for CIMZIA 2X200 MG/ML(X3)START KT has been published 96 times since Jul 17, 2024, and over the history we have for it it has risen 10.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6072.5137 per EA |
|---|---|
| All-time high | $6072.5137 (May 13, 2026) |
| All-time low | $5512.3676 (Aug 21, 2024) |
| 52-week high | $6072.5137 |
| 52-week low | $5783.3464 |
| Median price | $5783.3464 |
| Average price | $5767.3385 |
| Largest weekly change | +5.0% (Jan 14, 2026) |
| Weeks tracked | 96 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CIMZIA 2X200 MG/ML(X3)START KT?
The current National Average Drug Acquisition Cost (NADAC) for CIMZIA 2X200 MG/ML(X3)START KT, manufactured by UCB, Inc., is $6072.5137 per EA (NDC 50474071081), effective May 13, 2026.
How has the price of CIMZIA 2X200 MG/ML(X3)START KT changed over time?
Over the history we have for it, the NADAC for CIMZIA 2X200 MG/ML(X3)START KT has risen 10.1%. It has been tracked across 96 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for CIMZIA 2X200 MG/ML(X3)START KT?
Since Jul 17, 2024, the NADAC for CIMZIA 2X200 MG/ML(X3)START KT has ranged from a low of $5512.3676 (Aug 21, 2024) to a high of $6072.5137 (May 13, 2026), with a median of $5783.3464 per EA.
Are there cheaper alternatives to CIMZIA 2X200 MG/ML(X3)START KT?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CIMZIA 2X200 MG/ML(X3)START KT, but none are currently priced below it.
Who manufactures CIMZIA 2X200 MG/ML(X3)START KT?
CIMZIA 2X200 MG/ML(X3)START KT (NDC 50474071081) is labeled by UCB, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification